VCP ScannerFree US Stock Screener & Financial AnalysisFree US Stock Screener

RedHill Biopharma Ltd. (RDHL) Total Return Calculator with Dividends Reinvested

RedHill Biopharma Ltd.

Popular:

The total return for RedHill Biopharma Ltd. (RDHL) stock is -48.99% over the past 12 months. So far it's down 1.94% this year. The 5-year total return is -99.98%, meaning $10,000 invested in RDHL stock 5 years ago would be worth $2 today. Total return includes price appreciation plus reinvesting any dividends paid out.

If you invested $10,000 in RDHL 1 year ago, it would be worth $5,101 today — you'd have lost $4,899.

With Dividends Reinvested$5,101-48.99%

Price Only (No DRIP)$5,101-48.99%

Period2025-05-08 → 2026-05-08

Price

Total Return (DRIP)

S&P 500

If You Invested $10,000 in RDHL

1Y$5,101-$4,899 (-49.0%)-49.0% CAGR

3Y$169-$9,831 (-98.3%)-74.3% CAGR

5Y$2-$9,998 (-100.0%)-82.4% CAGR

10Y$1-$9,999 (-100.0%)-60.9% CAGR

15Y$1-$9,999 (-100.0%)-46.2% CAGR

20Y$1-$9,999 (-100.0%)-37.2% CAGR

30Y$1-$9,999 (-100.0%)-26.7% CAGR

RedHill Biopharma Ltd. did not pay dividends during this period. Total return = price return.

Loading RDHL total return...

As of 2026-05-08

Returns at a Glance

Period	Total Return	CAGR	Price Only	Div. Contrib.	$10K →
YTD	-1.94%	—	-1.94%	—	$9,806
1Y	-48.99%	-48.99%	-48.99%	—	$5,101
3Y	-98.31%	-74.34%	-98.31%	—	$169
5Y	-99.98%	-82.44%	-99.98%	—	$2
10Y	-99.99%	-60.88%	-99.99%	—	$1
15Y	-99.99%	-46.22%	-99.99%	—	$1
20Y	-99.99%	-37.20%	-99.99%	—	$1
30Y	-99.99%	-26.67%	-99.99%	—	$1

Risk & Highlights

Best Year+33.33%2020

Worst Year-94.95%2022

Max Drawdown-70.45%2025-10-01 → 2026-03-30

Annual Returns

Year	Total Return	Price Return	Div.	S&P 500	vs S&P
2026YTD	-5.83%	-5.83%	—	+0.41%	-6.2pp
2025	-83.91%	-83.91%	—	+16.64%	-100.5pp
2024	-82.99%	-82.99%	—	+24.00%	-107.0pp
2023	-79.38%	-79.38%	—	+24.81%	-104.2pp
2022	-94.95%	-94.95%	—	-19.95%	-75.0pp

RDHL underperformed the S&P 500 by 79.53pp over the past year (-48.99% vs +30.54%).

Loading summary...

RDHL Peers' Total Return

Accurate peer set · 10 comparable names

Name	Mkt Cap	30D Rtn	YTD Total Rtn	1Y Total Rtn	Div Contrib	3Y Total Rtn	5Y Total Rtn	10Y Total Rtn
RDHLRedHill Biopharma Ltd.	$5M	+26.3%	-1.9%	-49.0%	—	-98.3%	-100.0%	-100.0%
CMPXCompass Therapeutics, Inc.	$253M	-66.1%	-64.6%	+2.8%	—	-47.4%	-59.3%	-78.5%
PRAXPraxis Precision Medicines, Inc.	$9.5B	+3.1%	+15.2%	+767.1%	—	+1956.2%	-14.9%	-20.9%
IRWDIronwood Pharmaceuticals, Inc.	$688M	+20.2%	-1.2%	+502.9%	—	-59.8%	-61.6%	-58.7%
SUPNSupernus Pharmaceuticals, Inc.	$3.0B	-0.2%	+4.2%	+63.4%	—	+40.1%	+75.6%	+223.7%
PTGXProtagonist Therapeutics, Inc.	$6.4B	-2.7%	+14.0%	+126.2%	—	+298.6%	+251.2%	+749.2%
ARWRArrowhead Pharmaceuticals, Inc.	$10.2B	+12.9%	+7.2%	+448.5%	—	+79.7%	+10.0%	+1161.8%
PAHCPhibro Animal Health Corporation	$1.6B	-31.8%	+7.6%	+81.9%	+2.2pp	+188.4%	+57.5%	+113.5%
MNKDMannKind Corporation	$1.1B	+34.9%	-37.1%	-24.0%	—	-9.3%	-13.5%	-46.7%
TLRYTilray Brands, Inc.	$648M	-17.6%	-42.8%	+1157.1%	—	+100.0%	-63.0%	-75.2%
MCKMcKesson Corporation	$90.2B	-15.5%	-10.5%	+7.2%	+0.5pp	+102.1%	+270.4%	+339.0%

Compare:RDHL vs CMPX RDHL vs PRAX RDHL vs IRWD RDHL vs CMPX vs PRAX

About RDHL Dividend Returns

RedHill Biopharma Ltd. (RDHL) does not currently pay dividends. Many growth-focused companies reinvest profits back into the business rather than distributing them as dividends.

How We Calculate Total Return

Our total return calculator simulates dividend reinvestment (DRIP) by assuming each dividend payment is used to purchase additional shares at the closing price on the ex-dividend date. This methodology provides an accurate representation of how a dividend reinvestment plan would perform.

Frequently Asked Questions

Q1What is the total return of RDHL over the past year?

RedHill Biopharma Ltd. (RDHL) delivered a return of -48.99% over the past year. Since RDHL does not currently pay dividends, the total return equals the price-only return.

Q2How much would $10,000 invested in RDHL be worth today?

A $10,000 investment in RedHill Biopharma Ltd. one year ago would be worth $5,101 today, representing a loss of $4,899.

Q3Does RDHL pay dividends?

RedHill Biopharma Ltd. (RDHL) does not currently pay dividends. Many growth-focused companies reinvest profits back into the business rather than distributing them as dividends. For RDHL, the total return equals the price-only return.

Q4Did RDHL beat the S&P 500?

No, RedHill Biopharma Ltd. (RDHL) underperformed the S&P 500 by 79.53 percentage points over the past year. RDHL delivered a total return of -48.99%, compared to the S&P 500's 30.54%. This means a passive S&P 500 index fund outperformed RDHL by 79.53pp during this period.

Q5What is RDHL's worst drawdown?

RedHill Biopharma Ltd. (RDHL) experienced a maximum drawdown of -70.45% over the past year, declining from its peak on 2025-10-01 to its trough on 2026-03-30. The stock has not yet fully recovered to its prior peak. Maximum drawdown measures the worst peak-to-trough decline and is an important risk metric for investors.

Q6What is RDHL's long-term total return over 10, 20, or 30 years?

Here are RedHill Biopharma Ltd. (RDHL)'s long-term returns with dividends reinvested. Over 10 years, the total return is -100.0% (-60.9% CAGR) — $10,000 would have grown to $1. Over 20 years: -100.0% total return (-37.2% CAGR) — $10,000 → $1. Over 30 years: -100.0% total return (-26.7% CAGR) — $10,000 → $1. Long-term investors benefit from compounding: dividends buy additional shares, which generate their own dividends, creating an exponential growth effect.

Q7What was RDHL's best and worst year?

RedHill Biopharma Ltd.'s best calendar year was 2020 with a total return of 33.3%. Its worst year was 2022 with a total return of -95.0%. This range shows the volatility investors should expect — the difference between the best and worst year is 128.3 percentage points.